MIPS
Index

MIPS - Quality Measures
Advancing Care Information Measures
Improvement Activities Measures

;

Measure ID Title eMeasure ID Measure Type NQF ID High Priority Submission Methods Risk Adjusted? Registry Measure?
118 Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) Process 0066 Registry
006 Coronary Artery Disease (CAD): Antiplatelet Therapy Process 0067 Registry
204 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet CMS164v5 Process 0068 Claims | Electronic Health Record | Cms Web Interface | Registry
065 Appropriate Treatment for Children with Upper Respiratory Infection (URI) CMS154v5 Process 0069 Electronic Health Record | Registry
007 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) CMS145v5 Process 0070 Electronic Health Record | Registry
442 Persistence of Beta-Blocker Treatment After a Heart Attack Process 0071 Registry
005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS135v5 Process 0081 Electronic Health Record | Registry
008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS144v5 Process 0083 Electronic Health Record | Registry
012 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation CMS143v5 Process 0086 Claims | Electronic Health Record | Registry
014 Age-Related Macular Degeneration (AMD): Dilated Macular Examination Process 0087 Claims | Registry
018 Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy CMS167v5 Process 0088 Electronic Health Record
019 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care CMS142v5 Process 0089 Claims | Electronic Health Record | Registry
Page 66 of 75